|
Tuesday 10th November 2020 |
Text too small? |
NZX Regulation advises that, at the request of the company, Abano Healthcare Group Limited (NZX: ABA ) ordinary shares remain in a halt.
The trading halt has been extended to allow for completion of an addendum report by Calibre Partners, the Independent Adviser under the scheme of arrangement proposal to reflect updated financial information provided by ABA, and to allow for that report to be considered by the parties to the scheme of arrangement and released.
The trading halt will remain in place until the earlier of:
• An announcement by ABA in relation to the updated information; or
• Market open on Thursday, 12 November 2020.
See the links below for more details:
ABA – Trading Halt of Securities
Source: Abano Healthcare Group Limited
No comments yet
SPK - Response to open letter regarding FY26 financial statements
HGH - Update on proposed TSB transaction target completion date
MFT - Mainfreight Half Year Financial Results 30 September 2026
MCY - Executive leadership team changes
November 12th Morning Report
GTK - FY26 Investor Briefing Details
ERD - HY27 Financial Results Briefing Details - Amended
SEK - Forsyth Barr Initiates Coverage on Seeka
PHL - HY27 results: first dividend and upgraded guidance
PYS - PaySauce to announce F27 interim results on 26 Nov 2026